[R01] Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease
Ente: National Institute on Aging
Scadenza: 2027-05-31
Importo max: $2,002,901
Paese: US
Descrizione
Project Summary/Abstract
Alzheimer’s disease (AD) is a gradually progressive neurodegenerative disorder that results in total cognitive
and functional loss. To date, disease-modifying therapeutics and secondary prevention efforts have proven
ineffective in combating this public health burden, which
Settori: National Institute on Aging
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.